These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32984757)

  • 21. Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant.
    Taoutel R; Ezekowitz MD; Chaudhry UA; Weber C; Hassan D; Gracely EJ; Kamareddine MH; Horn BI; Harper GR
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101130. PubMed ID: 36246771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database.
    Khachatryan A; Doobaree IU; Spentzouris G; Gusto G; Zawaneh Y; Mughal F; Anastassopoulou A; Manu M; Fay M
    Adv Ther; 2023 Feb; 40(2):504-520. PubMed ID: 36399317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative antithrombotic management of patients who receive direct oral anticoagulants during gastroenterological surgery.
    Fujikawa T; Takahashi R; Naito S
    Ann Gastroenterol Surg; 2020 May; 4(3):301-309. PubMed ID: 32490344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct oral anticoagulants and cardiac surgery: A descriptive study of preoperative management and postoperative outcomes.
    Fox V; Kleikamp A; Dittrich M; Zittermann A; Flieder T; Knabbe C; Gummert J; Birschmann I
    J Thorac Cardiovasc Surg; 2021 May; 161(5):1864-1874.e2. PubMed ID: 31982117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Shah S; Nayfeh T; Hasan B; Urtecho M; Firwana M; Saadi S; Abd-Rabu R; Nanaa A; Flynn DN; Rajjoub NS; Hazem W; Seisa MO; Hassett LC; Spyropoulos AC; Douketis JD; Murad MH
    Chest; 2023 May; 163(5):1245-1257. PubMed ID: 36462533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
    Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
    Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants.
    Testa S; Legnani C; Antonucci E; Paoletti O; Dellanoce C; Cosmi B; Pengo V; Poli D; Morandini R; Testa R; Tripodi A; Palareti G;
    J Thromb Haemost; 2019 Jul; 17(7):1064-1072. PubMed ID: 31013383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
    Tapaskar N; Ham SA; Micic D; Sengupta N
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants.
    Brodie MM; Newman JC; Smith T; Rockey DC
    Am J Med; 2018 May; 131(5):573.e9-573.e15. PubMed ID: 29175237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication.
    Schaefer JK; Errickson J; Li Y; Kong X; Alexandris-Souphis T; Ali MA; Decamillo D; Haymart B; Kaatz S; Kline-Rogers E; Kozlowski JH; Krol GD; Shankar SR; Sood SL; Froehlich JB; Barnes GD
    JAMA Intern Med; 2021 Jun; 181(6):817-824. PubMed ID: 33871544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure.
    Shaw JR; Li N; Vanassche T; Coppens M; Spyropoulos AC; Syed S; Radwi M; Duncan J; Schulman S; Douketis JD
    Blood Adv; 2020 Aug; 4(15):3520-3527. PubMed ID: 32756938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis.
    Shaw JR; Zhang T; Le Gal G; Douketis J; Carrier M
    Res Pract Thromb Haemost; 2020 Jan; 4(1):131-140. PubMed ID: 31989095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs).
    Nemola G; Russi A; Cozzani G; Leo G; Vetrugno L; Sparasci FM; Parlati AL; Della Bella P; Montorfano M; Tresoldi M; Salerno A; Cera M; Mattiello P; Comi G; Maisano F; Zangrillo A; Gaspardone C; Melillo F; Margonato A; Godino C;
    Am J Cardiol; 2023 Nov; 206():125-131. PubMed ID: 37703678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential for a Virtual Care Model in the Perioperative Management of Anticoagulant Therapy: A 5-Year Retrospective Clinic Review.
    Douketis JL; Schulman S
    TH Open; 2023 Jul; 7(3):e184-e190. PubMed ID: 37415616
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation.
    An J; Bider Z; Luong TQ; Cheetham TC; Lang DT; Fischer H; Reynolds K
    J Am Heart Assoc; 2021 Nov; 10(21):e021601. PubMed ID: 34713708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation.
    Søgaard M; Ording AG; Skjøth F; Larsen TB; Nielsen PB
    Eur Heart J Cardiovasc Pharmacother; 2024 Feb; 10(2):137-146. PubMed ID: 37993415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Harrington J; Carnicelli AP; Hua K; Wallentin L; Patel MR; Hohnloser SH; Giugliano RP; Fox KAA; Hijazi Z; Lopes RD; Pokorney SD; Hong H; Granger CB
    Circulation; 2023 Jun; 147(23):1748-1757. PubMed ID: 37042255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation.
    Jansson M; Själander S; Sjögren V; Björck F; Renlund H; Norrving B; Själander A
    J Thromb Thrombolysis; 2023 Apr; 55(3):415-425. PubMed ID: 36607464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Periprocedural Management of Oral Anticoagulation.
    Shaw JR; Kaplovitch E; Douketis J
    Med Clin North Am; 2020 Jul; 104(4):709-726. PubMed ID: 32505262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.